Gu Li - Google Scholar
ucsd - Cited by 661 - liver cancer ... Y Zhu, LI Gu, XI Lin, X Zhou, B Lu, C Liu, C Lei, F Zhou, Q Zhao, ... Cell reports 37 (13), 2021. 27: 2021: Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells.
Li Gu's research works | University of California, San Diego ...
Li Gu's 14 research works with 394 citations and 970 reads, including: Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by...
FBP1 controls liver cancer evolution from senescent MASH
Jan 1, 2025 · Here we identified the gluconeogenic enzyme fructose-1,6-bisphosphatase 1 (FBP1) as a p53 target that is elevated in senescent-like MASH hepatocytes but suppressed through promoter...
FBP1 controls liver cancer evolution from senescent MASH
Here we identified the gluconeogenic enzyme fructose-1,6-bisphosphatase 1 (FBP1) as a p53 target that is elevated in senescent-like MASH hepatocytes but suppressed through promoter hypermethylation and proteasomal degradation in most human HCCs.
Author Correction: FBP1 controls liver cancer evolution from
Jan 31, 2025 · Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, School of Medicine, University of California San Diego (UCSD), La Jolla, CA, USA. Li Gu, Maiya...
Li Gu - Agilent Technologies - LinkedIn
View Li Gu’s profile on LinkedIn, a professional community of 1 billion members. Experience: Agilent Technologies · Education: University of the Pacific · Location: Stockton · 158 connections...
- Connections: 158
- Location: Agilent Technologies
Faculty Labs - University of California, San Diego
Department of Cellular and Molecular Medicine, UC San Diego School of Medicine
Li Gu - Google Scholar
Li Gu. Amgen, Inc. Verified email at amgen.com. Nanoparticle Drug delivery Vaccine. Articles Cited by Public access. Title. Sort. Sort by citations Sort by year Sort by title. Cited by. ... L Gu, LM Nusblat, N Tishbi, SC Noble, CM Pinson, E Mintzer, CM Roth, ... Journal of Controlled Release 184, 28-35, 2014. 20:
Li Gu - OpenReview
Promoting openness in scientific communication and the peer-review process
Too Much Insulin Can Be as Dangerous as Too Little
Apr 21, 2023 · Hypoglycemia (low blood sugar) is a significant cause of death among persons with diabetes. In the new study, Karin, first author Li Gu, PhD, a postdoctoral scholar in Karin’s lab, and colleagues describe “the body’s natural defense or …